viruses a549 cells Search Results


viruses a549  (ATCC)
95
ATCC viruses a549
Viruses A549, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/viruses a549/product/ATCC
Average 95 stars, based on 1 article reviews
viruses a549 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
a549  (InvivoGen)
93
InvivoGen a549
A549, supplied by InvivoGen, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549/product/InvivoGen
Average 93 stars, based on 1 article reviews
a549 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
viruses a549 human lung adenocarcinoma cells  (ATCC)
99
ATCC viruses a549 human lung adenocarcinoma cells
Viruses A549 Human Lung Adenocarcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/viruses a549 human lung adenocarcinoma cells/product/ATCC
Average 99 stars, based on 1 article reviews
viruses a549 human lung adenocarcinoma cells - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
virus infected a549 cells  (ATCC)
95
ATCC virus infected a549 cells
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
Virus Infected A549 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/virus infected a549 cells/product/ATCC
Average 95 stars, based on 1 article reviews
virus infected a549 cells - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier
virus propagation a549 at cells31  (DSMZ)
96
DSMZ virus propagation a549 at cells31
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
Virus Propagation A549 At Cells31, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/virus propagation a549 at cells31/product/DSMZ
Average 96 stars, based on 1 article reviews
virus propagation a549 at cells31 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier
a549-hace2 cells  (BEI Resources)
90
BEI Resources a549-hace2 cells
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
A549 Hace2 Cells, supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549-hace2 cells/product/BEI Resources
Average 90 stars, based on 1 article reviews
a549-hace2 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human lung epithelial cell line a549  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection human lung epithelial cell line a549
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
Human Lung Epithelial Cell Line A549, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung epithelial cell line a549/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
human lung epithelial cell line a549 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
crl 11268 hela hiv reagent program  (ATCC)
99
ATCC crl 11268 hela hiv reagent program
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
Crl 11268 Hela Hiv Reagent Program, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crl 11268 hela hiv reagent program/product/ATCC
Average 99 stars, based on 1 article reviews
crl 11268 hela hiv reagent program - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
human lung adenocarcinoma epithelial a549 cells  (BioResource International Inc)
90
BioResource International Inc human lung adenocarcinoma epithelial a549 cells
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
Human Lung Adenocarcinoma Epithelial A549 Cells, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung adenocarcinoma epithelial a549 cells/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
human lung adenocarcinoma epithelial a549 cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
candida glabrata meyer et yarrow  (ATCC)
90
ATCC candida glabrata meyer et yarrow
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
Candida Glabrata Meyer Et Yarrow, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/candida glabrata meyer et yarrow/product/ATCC
Average 90 stars, based on 1 article reviews
candida glabrata meyer et yarrow - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
vero  (ATCC)
99
ATCC vero
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
Vero, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vero/product/ATCC
Average 99 stars, based on 1 article reviews
vero - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier
viruses 100 a549 hace2 cells  (InvivoGen)
96
InvivoGen viruses 100 a549 hace2 cells
( a ) <t>A549</t> cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)
Viruses 100 A549 Hace2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/viruses 100 a549 hace2 cells/product/InvivoGen
Average 96 stars, based on 1 article reviews
viruses 100 a549 hace2 cells - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

Image Search Results


( a ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)

Journal: Nature Communications

Article Title: A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action

doi: 10.1038/ncomms14234

Figure Lengend Snippet: ( a ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8, Rituximab (negative control) or Cetuximab (positive control) prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. ( b ) A549 cells infected with B/Brisbane/60/2008 were labelled with 46B8 or 46B8 N297G prior to incubation with NK cells. Target cell lysis was presented as the percent of LDH release. The assays were done in duplicate. Results are representative of three independent experiments. ( a , b : mean and s.e.m.)

Article Snippet: For CDC assay, virus-infected A549 cells or WIL2-S cells (ATCC, CRL-8885, expressing CD20) were coated with varying concentrations of 46B8 or Rituximab.

Techniques: Infection, Negative Control, Positive Control, Incubation, Activation Assay, Lysis

( a ) A549 cells infected with WT or mutant B/Brisbane/60/2008 viruses were labelled with 46B8 prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. The assays were done in duplicate. Results are representative of three independent experiments. ( b , c ) DBA/2 J mice were infected intranasally with a minimum lethal dose of the WT or mutant B/Brisbane/60/2008 viruses. At 72 h post infection, mice received a single treatment of 46B8, 46B8 N297G or a control IgG intravenously at 15 mg kg −1 . ( b ) Survival curves. Each group contains eight mice. Log-rank tests of 46B8- versus control IgG-treated groups for all viruses, 46B8 N297G- versus control IgG-treated groups for WT, B1 and C2 and 46B8- versus 46B8 N297G-treated groups for A4, B1 and C2 give P <0.05. ( c ) Percent of average BW of survived mice as compared with the average pre-infection weight. ( a : mean and s.e.m.; c : mean and s.d.)

Journal: Nature Communications

Article Title: A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action

doi: 10.1038/ncomms14234

Figure Lengend Snippet: ( a ) A549 cells infected with WT or mutant B/Brisbane/60/2008 viruses were labelled with 46B8 prior to incubation with NK cells. NK cell activation (left panel) and target cell lysis (right panel) were presented as the frequency of CD107a + cells and the percent of LDH release, respectively. The assays were done in duplicate. Results are representative of three independent experiments. ( b , c ) DBA/2 J mice were infected intranasally with a minimum lethal dose of the WT or mutant B/Brisbane/60/2008 viruses. At 72 h post infection, mice received a single treatment of 46B8, 46B8 N297G or a control IgG intravenously at 15 mg kg −1 . ( b ) Survival curves. Each group contains eight mice. Log-rank tests of 46B8- versus control IgG-treated groups for all viruses, 46B8 N297G- versus control IgG-treated groups for WT, B1 and C2 and 46B8- versus 46B8 N297G-treated groups for A4, B1 and C2 give P <0.05. ( c ) Percent of average BW of survived mice as compared with the average pre-infection weight. ( a : mean and s.e.m.; c : mean and s.d.)

Article Snippet: For CDC assay, virus-infected A549 cells or WIL2-S cells (ATCC, CRL-8885, expressing CD20) were coated with varying concentrations of 46B8 or Rituximab.

Techniques: Infection, Mutagenesis, Incubation, Activation Assay, Lysis, Control